ACR Appropriateness Criteria® resectable rectal cancer Journal Article


Authors: Jones, W. E. 3rd; Thomas, C. R. Jr; Herman, J. M.; Abdel-Wahab, M.; Azad, N.; Blackstock, W.; Das, P.; Goodman, K. A.; Hong, T. S.; Jabbour, S. K.; Konski, A. A.; Koong, A. C.; Rodriguez-Bigas, M.; Small, W. Jr; Zook, J.; Suh, W. W.
Article Title: ACR Appropriateness Criteria® resectable rectal cancer
Abstract: The management of resectable rectal cancer continues to be guided by clinical trials and advances in technique. Although surgical advances including total mesorectal excision continue to decrease rates of local recurrence, the management of locally advanced disease (T3-T4 or N+) benefits from a multimodality approach including neoadjuvant concomitant chemotherapy and radiation. Circumferential resection margin, which can be determined preoperatively via MRI, is prognostic. Toxicity associated with radiation therapy is decreased by placing the patient in the prone position on a belly board, however for patients who cannot tolerate prone positioning, IMRT decreases the volume of normal tissue irradiated. The use of IMRT requires knowledge of the patterns of spreads and anatomy. Clinical trials demonstrate high variability in target delineation without specific guidance demonstrating the need for peer review and the use of a consensus atlas. Concomitant with radiation, fluorouracil based chemotherapy remains the standard, and although toxicity is decreased with continuous infusion fluorouracil, oral capecitabine is non-inferior to the continuous infusion regimen. Additional chemotherapeutic agents, including oxaliplatin, continue to be investigated, however currently should only be utilized on clinical trials as increased toxicity and no definitive benefit has been demonstrated in clinical trials.The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every two years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. © 2012 Jones et al.; Copyright American College of Radiology.
Keywords: cancer chemotherapy; cancer survival; treatment response; overall survival; review; intensity modulated radiation therapy; fluorouracil; drug efficacy; multimodality cancer therapy; capecitabine; cancer radiotherapy; disease free survival; postoperative care; radiation dose; chemotherapy; cancer staging; nuclear magnetic resonance imaging; tumor localization; radiotherapy; practice guideline; high risk patient; body posture; oxaliplatin; rectum cancer; chemoradiotherapy; rectal cancer; appropriateness criteria; cancer prognosis; supine position
Journal Title: Radiation Oncology
Volume: 7
ISSN: 1748-717X
Publisher: Biomed Central Ltd  
Date Published: 2012-09-01
Start Page: 161
Language: English
DOI: 10.1186/1748-717x-7-161
PROVIDER: scopus
PMCID: PMC3488966
PUBMED: 23006527
DOI/URL:
Notes: --- - "Export Date: 14 February 2013" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karyn A Goodman
    257 Goodman